Coxsackievirus B5 infection induces dysregulation of microRNAs predicted to target known type 1 diabetes risk genes in human pancreatic islets

KW Kim, A Ho, A Alshabee-Akil, AA Hardikar… - Diabetes, 2016 - Am Diabetes Assoc
KW Kim, A Ho, A Alshabee-Akil, AA Hardikar, TWH Kay, WD Rawlinson, ME Craig
Diabetes, 2016Am Diabetes Assoc
Extensive research has identified enterovirus (EV) infections as key environmental triggers
of type 1 diabetes. However, the underlying molecular mechanisms via which EVs contribute
to the pathogenesis of type 1 diabetes remain unclear. Given that EVs dysregulate host
microRNAs (miRNAs), which function as key regulators of β-cell biology, we investigated the
impact of coxsackievirus B5 (CVB5) infection on the cellular expression of miRNAs within
human islets. Using high-throughput quantitative PCR nanofluidics arrays, the expression of …
Extensive research has identified enterovirus (EV) infections as key environmental triggers of type 1 diabetes. However, the underlying molecular mechanisms via which EVs contribute to the pathogenesis of type 1 diabetes remain unclear. Given that EVs dysregulate host microRNAs (miRNAs), which function as key regulators of β-cell biology, we investigated the impact of coxsackievirus B5 (CVB5) infection on the cellular expression of miRNAs within human islets. Using high-throughput quantitative PCR nanofluidics arrays, the expression of 754 miRNAs was examined in CVB5-infected human pancreatic islets. In total, 33 miRNAs were significantly dysregulated (≥ threefold difference) in the infected compared with control islets (P < 0.05). Subsequently, these differentially expressed miRNAs were predicted to target mRNAs of 57 known type 1 diabetes risk genes that collectively mediate various biological processes, including the regulation of cell proliferation, cytokine production, the innate immune response, and apoptosis. In conclusion, we report the first global miRNA expression profiling of CVB5-infected human pancreatic islets. We propose that EVs disrupt the miRNA-directed suppression of proinflammatory factors within β-cells, thereby resulting in an exacerbated antiviral immune response that promotes β-cell destruction and eventual type 1 diabetes.
Am Diabetes Assoc